CRNX insider notices exercise and 10b5-1 sales

CRNX filing reports proposed and recent sales of Common Stock by an affiliated holder.

Rhea-AI Filing Summary

CRNX filing reports proposed and recent sales of Common Stock by an affiliated holder. The filing lists an exercise of stock options for 20,900 shares on 04/14/2026 (cash exercise) and multiple 10b5-1 sales executed by Jeff Knight: 9,911 shares on 03/16/2026, 85,163 shares on 04/08/2026, and 4,434 shares on 04/13/2026, with cash proceeds shown per trade.

Insights

Securities Compliance Analyst

Routine Rule 144 notice tied to option exercise and scheduled 10b5-1 sales.

The filing records an exercise of stock options for 20,900 shares on 04/14/2026 and lists prior 10b5-1 dispositions by Jeff Knight on 03/16/2026, 04/08/2026, and 04/13/2026. The 10b5-1 entries show executed share counts and gross proceeds per trade.

These disclosures are procedural under Rule 144 and do not, by themselves, indicate discretionary trading outside a prearranged plan. Subsequent filings would show any additional dispositions or changes to planned sales.

Key Figures

Option exercise: 20,900 shares 10b5-1 sale: 9,911 shares 10b5-1 sale: 85,163 shares +1 more

4 metrics

Option exercise 20,900 shares exercise of stock options on 04/14/2026 (cash exercise)

10b5-1 sale 9,911 shares sale on 03/16/2026 with proceeds $370,411.47

10b5-1 sale 85,163 shares sale on 04/08/2026 with proceeds $3,414,701.10

10b5-1 sale 4,434 shares sale on 04/13/2026 with proceeds $177,438.04

Key Terms

Rule 144, 10b5-1, exercise of stock options

3 terms

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

10b5-1 regulatory

"10b5-1 Sales for JEFF KNIGHT"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

exercise of stock options financial

"Exercise of Stock Options | Issuer | 20900 | 04/14/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CRNX's Form 144 disclose about insider sales?

It discloses an exercise and recent scheduled sales totaling multiple share lots. The filing lists a 20,900-share option exercise on 04/14/2026 and 10b5-1 sales of 9,911, 85,163, and 4,434 shares on the dates shown.

Who executed the 10b5-1 sales in the CRNX filing?

The 10b5-1 sales were executed by Jeff Knight. The filing names Jeff Knight and shows sales on 03/16/2026, 04/08/2026, and 04/13/2026 with share counts and proceeds.

What proceeds are reported for the 10b5-1 trades in CRNX's filing?

Gross proceeds per trade are listed alongside each sale. The filing shows proceeds of $370,411.47, $3,414,701.10, and $177,438.04 for the three respective 10b5-1 transactions.

Does the filing state how the 20,900-share option exercise was funded?

Yes. The exercise of 20,900 shares on 04/14/2026 is shown as a cash exercise in the filing's securities-to-be-sold section.

Which broker-dealer is listed for the proposed sale activity?

The filing lists Morgan Stanley Smith Barney LLC at 1 New York Plaza as the broker-dealer associated with the securities to be sold in the document.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/14/2026 - 04:37 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001881007
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Crinetics Pharmaceuticals, Inc.
SEC File Number	001-38583
Address of Issuer	6055 Lusk Boulevard San Diego CALIFORNIA 92121
Phone	8584506464
Name of Person for Whose Account the Securities are To Be Sold	JEFF KNIGHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20900	807994.00	104705330	04/14/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/14/2026	Exercise of Stock Options	Issuer			20900	04/14/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	04/13/2026	4434	177438.04
10b5-1 Sales for JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	04/08/2026	85163	3414701.10
JEFF KNIGHT 6055 Lusk Boulevard San Diego CA 92121	Common	03/16/2026	9911	370411.47

144: Remarks and Signature

Remarks
Date of Notice	04/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jeff Knight
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)